The average follow-up time of 47 surviving patients was 46.25 months, mainly stage II disease was 100%, stage III was 62.5%, there were no stage IV patients.
Bệnh nhân sống ở giai đoạn II là 100%, giai đoạn III là 62,5%, không có bệnh nhân giai đoạn IV.